San Francisco, Feb. 10, 2016 -- Global Deep Brain Stimulators Market is expected to reach USD 1.59 billion by 2020. Increasing incidence rates of target neurological disorders such as Parkinson's and demand for minimally invasive surgical procedures are some primary factors expected to drive the deep brain stimulators market. Deep brain stimulators have witnessed a significant rise in usage rates and are now considered viable substitutes to conventional therapies. Higher efficacy exhibited by the former is a key reason attributing to the aforementioned conclusion. Introduction of technological advancements such as fractionation of electric current and selective current steering are also expected to improve device usage rates.
Deep brain stimulators are FDA approved when it comes to treating Parkinson's, dystonia and OCD (obsessive compulsive disorder) etc. Moreover, the use of these devices for diseases such as trigeminal neuralgia, Tourette syndrome, Alzheimer's, refractory epilepsy, cluster headache and movement disorders by multiple sclerosis are awaiting FDA approval. The potential inclusion of new application areas is expected fuel the future growth of the market.
Browse Full Research Report With TOC On "Deep Brain Stimulators (DBS) Market Analysis By Application (Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder, Depression, Dystonia, Parkinsons Disease) And Segment Forecasts To 2020" at: http://www.radiantinsights.com/research/deep-brain-stimulators-dbs-market-analysis-by-application-pain-management-epilepsy-essential-tremor-obsessive-compulsive-disorder-depression-dystonia-parkinsons-disease-and-segment-forecasts-to-2020
Further key findings from the study suggest:
- Parkinson's disease was the largest application segment of the market in 2013. Use of deep brain stimulators for treating this disease renders symptomatic relief from medicine induced dyskinesia and therefore, these devices are expected to witness a rapid growth in demand during the forecast period.
- OCD (obsessive compulsive disorder) was also one of the leading application segments in 2013. DBS has proven to be the most efficient treatment option pertaining to OCD and is expected to witness a rapid growth in usage rates over the next six years.
- North America was the largest regional market, accounting for over 50.0% of market share in 2013. Presence of sophisticated healthcare infrastructure and reimbursement policies and increasing awareness levels of patients and healthcare personnel are some key factors expected to drive regional market growth during the forecast period.
- Asia Pacific is identified as the most lucrative market. Rapidly improving healthcare infrastructure, presence of high unmet medical needs and increasing healthcare spending levels in the emerging markets of China and India are some factors attributing to its growth.
- Some key manufacturers of deep brain stimulators include St. Jude Medical, Medtronic Plc, Boston Scientific Corporation and Aleva Neurotherapeutics SA.
- The market is marked by the presence of extensive R&D investments targeting the development of technologically advanced systems catering to new application areas. Moreover, manufacturers participate in endeavors directed towards capitalizing on the untapped opportunities available in the emerging Asia Pacific and Latin American markets.
Browse All Reports of This Category at: www.radiantinsights.com/catalog/medical-devices
Global Deep Brain Stimulators Application Outlook (Revenue, USD Million, 2012 - 2020)
- Pain Management
- Epilepsy
- Essential Tremor
- Obsessive Compulsive Disorder (OCD)
- Depression
- Dystonia
- Parkinson's Disease
- Others
Deep Brain Stimulators Regional Outlook (Revenue, USD Billion, 2012 - 2020)
- North America
- S.
- Europe
- Germany
- UK
- Asia Pacific
- Japan
- RoW
Related Reports by Radiant Insights:
- Business Intelligence (BI) Market in Retail Industry –
- Mammography Equipment Market –
http://www.radiantinsights.com/research/global-mammography-equipment-market-2014-2018
About Radiant Insights
Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy.Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: [email protected]
Web: http://www.radiantinsights.com/


Nomura Shares Drop After Profit Miss Despite Strong Revenue Growth
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
Kia Cuts EV Prices in Europe as Chinese Carmakers Intensify Competition
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
SMC Corp Stock Surges as Palliser Capital Pushes for Major Share Buyback
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals 



